echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers Res Ther: Professor Han Ying's team found that gut microbiota combined with plasma Aβ can be used as a potential marker to identify preclinical AD

    Alzheimers Res Ther: Professor Han Ying's team found that gut microbiota combined with plasma Aβ can be used as a potential marker to identify preclinical AD

    • Last Update: 2022-05-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the team of Professor Han Ying from the National Clinical Research Center for Geriatric Diseases (Xuanwu Hospital)-China AD Pre-clinical Alliance and the Department of Neurology, Xuanwu Hospital, Capital Medical University, published an article entitled "Combination of gut microbiota and plasma" in the international academic journal Alzheimers Research & Therapy.


    Studies have found that plasma Aβ may contribute to the early identification of patients with Aβ deposition in the brain


    The results of the study showed that plasma Aβ42 and Aβ42/Aβ40 levels were significantly decreased in the CN+ group compared with the CN- group (p = 0.


    In terms of intestinal flora, the relative abundances of Firmicutes and δ-Proteobacteria decreased significantly in CN+ group, while the relative abundance of Bacteroidetes increased significantly (Fig.


    Notably, the relative abundance of Firmicutes and the short-chain fatty acid-producing bacteria to which they belong showed a gradual change from CN- to CN+ to CI (Fig.


    Furthermore, for all subjects, whole-brain Aβ deposition levels correlated with plasma Aβ42/Aβ40 (r = -0.


    Finally, combined plasma Aβ markers, gut microbiota, and cognitive scores showed a relatively high ability to discriminate the CN+ group (AUC = 0.


    This study provides preliminary evidence for the change of intestinal flora in the preclinical stage of AD, and the combination of plasma Aβ index and intestinal microbial index may be used as a non-invasive, simple and easy-to-promote early AD diagnosis marker, which is an early stage of AD.


    Thanks for the support of the National Natural Science Foundation of China! Thank you to all the volunteers who participated in this project for their support!

    references:

    Sheng C, Yang K,He B, Du W, Cai Y, Han Y.


    Research Introduction

    Article Essentials

    The results of the study showed that plasma Aβ42 and Aβ42/Aβ40 levels were significantly decreased in the CN+ group compared with the CN- group (p = 0.


    In terms of intestinal flora, the relative abundances of Firmicutes and δ-Proteobacteria decreased significantly in CN+ group, while the relative abundance of Bacteroidetes increased significantly (Fig.


    Notably, the relative abundance of Firmicutes and the short-chain fatty acid-producing bacteria to which they belong showed a gradual change from CN- to CN+ to CI (Fig.


    Furthermore, for all subjects, whole-brain Aβ deposition levels correlated with plasma Aβ42/Aβ40 (r = -0.


    Finally, combined plasma Aβ markers, gut microbiota, and cognitive scores showed a relatively high ability to discriminate the CN+ group (AUC = 0.


    diagnosis

    Thanks

    Thanks for the support of the National Natural Science Foundation of China! Thank you to all the volunteers who participated in this project for their support!

    Natural Science Foundation

    references:

    Sheng C, Yang K,He B, Du W, Cai Y, Han Y.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.